Ownership and insider activity for Cibus, Inc. (CBUS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name.
Price
| Price | $1.51 |
| Market Cap | $115M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-08 | Wichner Craig | A-Award | 1,047,620 | $1.3M |
| 2026-06-08 | Wichner Craig | A-Award | 894,309 | |
| 2026-06-02 | Finn Mark Terrence | A-Award | 77,586 | $108K |
| 2026-06-02 | Moretti August J | A-Award | 77,586 | $108K |
| 2026-06-02 | RIGGS RORY B | A-Award | 77,586 | $108K |
| 2026-06-02 | Prante Gerhard | A-Award | 64,748 | |
| 2026-06-02 | Lehmann Jean-Pierre Jules | A-Award | 64,748 | |
| 2026-06-02 | Box Kimberly Ann | A-Award | 77,586 | $108K |
| 2026-06-02 | Wichner Craig | A-Award | 77,586 | $108K |
| 2026-06-02 | Urban Thomas | A-Award | 64,748 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.0M | $56.7M | $93.8M | $58.6M | $17.3M | $13.8M | $3.4M | $32.7M | $14.4M | $9.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | $11.7M | 0 | 0 | 0 | 0 | 0 |
| Receivables | $157000 | $167000 | $46000 | $1.1M | $4.9M | 0 | 0 | $530000 | $1.0M | $703000 |
| Inventory | 0 | 0 | 0 | $2.6M | $1.4M | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $5.5M | $57.5M | $95.5M | $63.5M | $39.6M | $15.2M | $4.1M | $35.2M | $16.9M | $12.1M |
| Property, Plant & Equipment | $11.0M | $14.4M | $21.9M | $23.2M | $22.9M | $21.7M | $18.1M | $37.5M | $44.7M | $27.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $434.9M | $253.5M | $232.5M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | $158000 | $35.4M | $33.6M | $31.7M |
| Total Assets | $16.6M | $72.2M | $118.8M | $88.1M | $63.3M | $37.2M | $22.4M | $544.4M | $350.1M | $305.0M |
| Accounts Payable | $357000 | $1.0M | $818000 | $1.1M | $929000 | $1.3M | $340000 | $6.1M | $6.0M | $8.1M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $833000 | $436000 | $3.2M |
| Total Current Liabilities | $2.9M | $4.3M | $7.0M | $7.2M | $6.9M | $4.9M | $1.7M | $21.3M | $19.9M | $16.9M |
| Long-term Debt | 0 | 0 | 0 | 0 | $1.5M | 0 | 0 | $536000 | $226000 | $235.0M |
| Total Liabilities | $3.5M | $14.7M | $25.4M | $25.6M | $26.5M | $23.1M | $15.2M | $206.1M | $252.2M | $283.2M |
| Retained Earnings | -$28.6M | -$54.5M | -$82.4M | -$122.1M | -$166.9M | -$196.1M | -$212.2M | -$479.8M | -$731.2M | -$858.3M |
| Total Equity | $13.1M | $57.5M | $93.4M | $62.5M | $36.9M | $14.1M | $7.2M | $293.5M | $92.2M | $21.8M |
| Total Debt | 0 | $10.1M | $18.5M | $18.6M | $19.8M | $17.9M | $13.9M | $24.6M | $36.3M | $268.0M |
| Net Debt | -$5.0M | -$46.5M | -$75.3M | -$40.0M | -$9.2M | $4.1M | $10.5M | -$8.1M | $21.9M | $258.0M |
| Working Capital | $2.6M | $53.2M | $88.5M | $56.3M | $32.6M | $10.3M | $2.5M | $13.9M | -$2.9M | -$4.8M |
Financial Health
| Debt / Equity | 2.21 |
| Current Ratio | 1.62 |
Profitability
| Return on Equity | -320.60% |
| Return on Invested Capital | -17.82% |
| Return on Assets | -31.33% |
| Gross Margin | 45.73% |
| Operating Margin | -1240.90% |
| Net Margin | -2258.89% |
Related companies: ACRV · BMEA · CAMP · IMUX · MNOV · PMVP · RLMD
Explore sector: Healthcare · Biotechnology
More sections of CBUS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks